case studies for regenerative medicine standards development
TRANSCRIPT
![Page 1: Case Studies for Regenerative Medicine Standards Development](https://reader033.vdocuments.site/reader033/viewer/2022051710/5852c5ac1a28abfa398e0b60/html5/thumbnails/1.jpg)
Case Studies for Regenerative Medicine Standards
Development and Use Anthony Ratcliffe
Synthasome Inc, San Diego, CA
![Page 2: Case Studies for Regenerative Medicine Standards Development](https://reader033.vdocuments.site/reader033/viewer/2022051710/5852c5ac1a28abfa398e0b60/html5/thumbnails/2.jpg)
Scope of ASTM International Division IV (Medical and Surgical Materials and Devices): TEMPs
• The development of standards and promotion of related materials for tissue engineered medical products focusing on components of combination medical products intended to repair, replace or regenerate human tissue.
• These comprise the biological components such as the cells, tissue, cellular products, and/or biomolecules and biomaterials used in combination, including biologic, biomimetic and/or synthetic materials.
![Page 3: Case Studies for Regenerative Medicine Standards Development](https://reader033.vdocuments.site/reader033/viewer/2022051710/5852c5ac1a28abfa398e0b60/html5/thumbnails/3.jpg)
Articular Cartilage Repair and Regeneration
Synthasome, Inc
• Clinical Need • Research Need • Product Development Need • Manufacturing Need
![Page 4: Case Studies for Regenerative Medicine Standards Development](https://reader033.vdocuments.site/reader033/viewer/2022051710/5852c5ac1a28abfa398e0b60/html5/thumbnails/4.jpg)
Some features to Consider for Articular Cartilage Repair and
Regeneration
• Biomaterials • Cell culture and proliferation
• Product characterization (mechanical, biochemical etc)
• Product delivery
• Fixation in situ • Integration with host tissue • Pre-clinical study design • Pre-clinical outcomes • Clinical study design • Clinical outcomes
![Page 5: Case Studies for Regenerative Medicine Standards Development](https://reader033.vdocuments.site/reader033/viewer/2022051710/5852c5ac1a28abfa398e0b60/html5/thumbnails/5.jpg)
Applications for Articular Cartilage Repair Constructs
• Trauma • Focal articular
defects • Degenerative
joint disease
• Knee • Hip • Shoulder • Ankle • Digits
Synthasome, Inc
![Page 6: Case Studies for Regenerative Medicine Standards Development](https://reader033.vdocuments.site/reader033/viewer/2022051710/5852c5ac1a28abfa398e0b60/html5/thumbnails/6.jpg)
Carticel for Articular Repair • Autologous cell transplantation
– Tissue harvest – Cell culture and expansion – Re-implantation
• Clinical outcome is good to excellent – Similar to microfracture
• Expensive, profitability??? • Second generation products being developed
Synthasome, Inc
![Page 7: Case Studies for Regenerative Medicine Standards Development](https://reader033.vdocuments.site/reader033/viewer/2022051710/5852c5ac1a28abfa398e0b60/html5/thumbnails/7.jpg)
Tissue Engineered Articular Cartilage
HAO = 0.166 MPa
Et = 0.35 MPa
Synthasome, Inc
![Page 8: Case Studies for Regenerative Medicine Standards Development](https://reader033.vdocuments.site/reader033/viewer/2022051710/5852c5ac1a28abfa398e0b60/html5/thumbnails/8.jpg)
F2451 – SG for in vivo Assessment of Implantable Devices Intended to Repair
or Regenerate Articular Cartilage
• Products included may be composed of – Natural or synthetic biomaterials – Cells – Biologically active agents (growth factors, synthetic peptides,
plasmids, etc)
• Description and rationale of various animal models using a range of species
• Outcome measures –histologic, biochemical and mechanical – are briefly described
![Page 9: Case Studies for Regenerative Medicine Standards Development](https://reader033.vdocuments.site/reader033/viewer/2022051710/5852c5ac1a28abfa398e0b60/html5/thumbnails/9.jpg)
WK31014 – Standard test method using a goat in vivo model for testing articular
cartilage repair or regeneration • NIH funded project • Preliminary studies complete • Experimental design complete • Study to characterize model
ongoing • Model will allow for product
assessment for repair of small and large defects
• Model contains negative and positive controls
• Participation of industry, academia and FDA
![Page 10: Case Studies for Regenerative Medicine Standards Development](https://reader033.vdocuments.site/reader033/viewer/2022051710/5852c5ac1a28abfa398e0b60/html5/thumbnails/10.jpg)
Rotator Cuff Surgical Repair
• Clinical need – 4 million doctor visits per year
for rotator cuff problems – ~400,000 surgeries per year
in US – 30 - >90% failure rate
• R&D need – Multiple products on the
market, more being developed
Synthasome, Inc
![Page 11: Case Studies for Regenerative Medicine Standards Development](https://reader033.vdocuments.site/reader033/viewer/2022051710/5852c5ac1a28abfa398e0b60/html5/thumbnails/11.jpg)
Products for Reinforcement of Tendons and Soft Tissue
• Restore (DePuy)
• GraftJacket (Wright)
•ZCR Patch (Zimmer)
• TissueMend (Stryker)
• X-Repair (Synthasome)
Synthasome, Inc
![Page 12: Case Studies for Regenerative Medicine Standards Development](https://reader033.vdocuments.site/reader033/viewer/2022051710/5852c5ac1a28abfa398e0b60/html5/thumbnails/12.jpg)
F2903 – SG for Tissue Engineered Medical Products for Reinforcement of Tendon and Ligament Surgical Repair
• For the development, production and delivery of TEMPS intended to provide mechanical (functional) reinforcement of surgical repair of tendons and ligaments
• Products included may be composed one or combinations of two or more of matural ECM, synthetic biomaterials, cells, molecular mediators
• Products may be rapidly degrading, slowly degrading, or non-degrading
• Surgical repair may to tendon – tendon, tendon – bone, tendon – muscle, ligament – ligament, ligament – bone
![Page 13: Case Studies for Regenerative Medicine Standards Development](https://reader033.vdocuments.site/reader033/viewer/2022051710/5852c5ac1a28abfa398e0b60/html5/thumbnails/13.jpg)
Reinforcement of Tendon and Ligament Repair
X-Repair – Augmentation of Surgical Repair for Tendons and soft tissues
ASTM D2579 ASTM D3786 ASTM D5035 ASTM D5587 ASTM F1635 ISO 10993 ISO 11135
ASTM F2211 ASTM F2312 ASTM F2027 ASTM F2150 ASTM F2903
![Page 14: Case Studies for Regenerative Medicine Standards Development](https://reader033.vdocuments.site/reader033/viewer/2022051710/5852c5ac1a28abfa398e0b60/html5/thumbnails/14.jpg)
F2212 – SG for Characterization of Type I Collagen as Starting Material for Surgical
Implants and Substrates for TEMPs
• Provides guidance on Collagen Type I analysis
• Serves as key document in guiding the development of TEMPs products under development
• Allows objective comparison with products on market
![Page 15: Case Studies for Regenerative Medicine Standards Development](https://reader033.vdocuments.site/reader033/viewer/2022051710/5852c5ac1a28abfa398e0b60/html5/thumbnails/15.jpg)
Summary
• Standards provide a rationale approach to assess and compare technology safety and effectiveness
• Use of standards can increase efficiency of regulatory submissions